Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...
Teva Pharmaceutical Industries is able to absorb any potential tariffs imposed by the Trump administration, the company said ...
Teva has issued a voluntary recall of more than 500,000 bottles of the widely used blood pressure medication prazosin ...
See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.
Teva shares jumped 12% after Q3 earnings beat estimates, driven by strong branded drug sales led by Austedo and solid ...
Teva Pharmaceuticals Inc. surged after sales of branded medications topped expectations, showing that its strategy to expand into that drug category is working.
The positions in the table below reflect the Teva Pharmaceuticals USA, Inc.'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position ...
What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday outlined that Weiss executed a sale ...
Janssen sued Teva in the US District Court for the District of New Jersey under the Hatch-Waxman Act after Teva filed an abbreviated new drug application (ANDA) on a generic version of Invega Sustenna ...
In the last three months, 4 analysts have published ratings on Teva Pharmaceutical Indus (NYSE:TEVA), offering a diverse range of perspectives from bullish to bearish. Summarizing their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results